This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07010/identifier/pdb/
n14http://bio2rdf.org/drugbank:
n4http://linked.opendata.cz/resource/drugbank/drug/DB07010/identifier/pubchem-compound/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07010/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB07010/identifier/drugbank/
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB07010/identifier/chemspider/

Statements

Subject Item
n2:DB07010
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n10:DB07010 n14:DB07010
dcterms:title
N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE
adms:identifier
n4:10134160 n7:99443481 n11:DB07010 n12:33A n13:22376242
n5:IUPAC-Name
n6:271B40BC-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B40C2-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B40C1-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B40BE-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B40BF-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B40C0-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B40BA-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B40B8-363D-11E5-9242-09173F13E4C5 n6:271B40BB-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B40B9-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B40C8-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B40C9-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B40C3-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B40C4-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B40C6-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B40C5-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B40C7-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B40CE-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B40D0-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B40D1-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B40CD-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B40CC-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B40CF-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B40BD-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B40CA-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B40CB-363D-11E5-9242-09173F13E4C5